FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA documents a supplemental application for ondansetron submitted by Hospira, Inc., indicating an FDA regulatory action on this product (consistent with a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)